Tag: Viracept

Nelfinavir, an antiretroviral medication used to treat human immunodeficiency virus (HIV) infection, was first approved by the FDA in 1997. The generic for nelfinavir is known by its chemical name, nelfinavir mesylate, but a therapeutically equivalent generic version is currently not available in the United States.

Nelfinavir, an antiretroviral medication approved by the FDA in 1997, is not an antibiotic but a protease inhibitor used in the treatment of human immunodeficiency virus (HIV). This distinction is crucial for understanding how the drug works and why it targets viral infections rather than bacterial ones.

Globally, 77% of people living with HIV were accessing antiretroviral therapy at the end of 2024 [1.9.1]. A key component of this therapy involves specific drug classes. So, **what is the classification of Nelfinavir?** It is an antiretroviral drug belonging to the protease inhibitor (PI) class [1.2.1, 1.2.3].